Abbott Laboratories raises dividend for 45th straight year
Abbott Laboratories (ABT) will raise its dividend by 1.9%.
The quarterly dividend will be increased from $0.26 to $0.265 per share, marking 45 consecutive years of dividend growth, adjusted for the AbbVie spin-off.
The cash dividend is payable Feb. 15, 2017, to shareholders of record at the close of business on Jan. 13, 2017 and marks the 372nd consecutive quarterly dividend to be paid by Abbott since 1924.
Dividend Aristocrat Abbott has increased its dividend for 45 consecutive years now.
Abbott’s products include pharmaceuticals, nutritional, diagnostics, and vascular products.
The new annual dividend of $1.06 per share translates into an estimated yield of 2.7% at a stock price of $39.20.
Earlier this year AbbVie already raised its dividend (+12.3%), also marking 45 years of consecutive (post Abbott separation) dividend increases.
The quarterly dividend will be increased from $0.26 to $0.265 per share, marking 45 consecutive years of dividend growth, adjusted for the AbbVie spin-off.
The cash dividend is payable Feb. 15, 2017, to shareholders of record at the close of business on Jan. 13, 2017 and marks the 372nd consecutive quarterly dividend to be paid by Abbott since 1924.
Dividend Aristocrat Abbott has increased its dividend for 45 consecutive years now.
Abbott’s products include pharmaceuticals, nutritional, diagnostics, and vascular products.
The new annual dividend of $1.06 per share translates into an estimated yield of 2.7% at a stock price of $39.20.
Earlier this year AbbVie already raised its dividend (+12.3%), also marking 45 years of consecutive (post Abbott separation) dividend increases.